7.38
2.22%
0.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IOVA?
Forum
Prognose
Aktiensplit
Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
48.34%
0.715
|
0.482 | 0.469 | 0.238 | - |
Cost Of Revenue |
66.35%
7.261
|
4.365 | 4.34 | 2.05 | - |
Gross Profit |
68.58%
-6.546
|
-3.883 | -3.871 | -1.812 | - |
Operating Expenses
|
5.28%
111.18
|
117.37 | 114.49 | 108.27 | 110.86 |
Benefits Costs and Expenses |
2.97%
115.10
|
118.62 | 115.47 | 107.24 | 107.37 |
Costs And Expenses |
2.71%
118.44
|
121.74 | 118.83 | 110.32 | 110.86 |
Operating Income/Loss |
2.91%
-117.72
|
-121.26 | -118.36 | -110.09 | -110.86 |
Income/Loss From Continuing Operations Before Tax |
3.18%
-114.38
|
-118.14 | -115.00 | -107.00 | -107.37 |
Income Tax Expense/Benefit, Deferred |
19.95%
-1.408
|
-1.759 | -1.243 | - | - |
Income Tax Expense/Benefit |
19.95%
-1.408
|
-1.759 | -1.243 | -0.477 | - |
Income/Loss From Continuing Operations After Tax |
2.92%
-112.98
|
-116.38 | -113.76 | -106.53 | -107.37 |
Net Income/Loss
|
2.92%
-112.98
|
-116.38 | -113.76 | -106.53 | -107.37 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
216.82%
266.22
|
-227.88 | 245.82 | 224.48 | 213.69 |
Diluted Average Shares |
216.82%
266.22
|
-227.88 | 245.82 | 224.48 | 213.69 |
Basic Earnings Per Share |
6.67%
-0.42
|
-0.45 | -0.46 | -0.47 | -0.50 |
Diluted Earnings Per Share |
6.67%
-0.42
|
-0.45 | -0.46 | -0.47 | -0.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):